• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN VISTEC; GAUZE/SPONGE, INTERNAL, X-RAY DETECTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN VISTEC; GAUZE/SPONGE, INTERNAL, X-RAY DETECTABLE Back to Search Results
Model Number 7148
Device Problems Break (1069); Material Separation (1562)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/18/2018
Event Type  malfunction  
Manufacturer Narrative
The incident sample has been requested but to date has not been received for evaluation.If the sample is received, or if additional information pertinent to the incident is obtained a follow-up report will be submitted.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The customer reported the gauze is shredding.
 
Manufacturer Narrative
An investigation was performed for the reported customer complaint: ¿the customer reported the gauze is shredding.¿ no lot number was provided.A review of the device history record (dhr) was unable to be performed.However, all dhrs are reviewed for accuracy prior to product release.In-process procedures are also in place to prevent nonconforming product in the manufacturing process.This ensures components and finished products meet all quality inspection standards.These controls include, but are not limited to: material verification/certification processes, dimensional specifications, statistical samplings, periodic audits, process inspections, machine maintenance/operation and personnel training and certification.Eleven (11) sponge samples were returned for evaluation.The product was opened and examined for fraying.During visual examination and cross examination of the sponges, fraying was observed.Two (2) of the sponges were open all the way which is not the recommend way to use the sponges.Two (2) other sponges had raw edges which is when the edges peek through the woven material.The reason for the hole in the product is due to the tinsel strength of the woven material becoming weak.This can occur during production when the material is pulled during the cutting process.The material can break.The location of the tear would not easily be observed during a visual inspection in production.Inspectors routinely examine a statistical sample both physically and visually.If the material did a complete tear out, then the roll would be evaluated.The lots must be deemed acceptable by passing inspections that are based on a valid sampling plan.The reported customer complaint is confirmed.The probable root cause was determined to be material weakened during production process.This complaint will be utilized for tracking and trending purposes.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VISTEC
Type of Device
GAUZE/SPONGE, INTERNAL, X-RAY DETECTABLE
Manufacturer (Section D)
COVIDIEN
1647 perkins rd
augusta GA 30913
MDR Report Key7677644
MDR Text Key114025303
Report Number1018120-2018-00125
Device Sequence Number1
Product Code GDY
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup,Followup
Report Date 10/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number7148
Device Catalogue Number7148
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/16/2018
Initial Date Manufacturer Received 07/02/2018
Initial Date FDA Received07/11/2018
Supplement Dates Manufacturer Received07/16/2018
08/08/2018
Supplement Dates FDA Received09/13/2018
10/04/2018
Patient Sequence Number1
-
-